Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -0.38% | -.--% | +11.81% |
04-03 | Kinnate Biopharma Inc. Announces Board Resignations | CI |
04-03 | Kinnate Biopharma Inc.(NasdaqGS:KNTE) dropped from NASDAQ Composite Index | CI |
Chart calendar Kinnate Biopharma Inc.
Upcoming events on Kinnate Biopharma Inc.
Past events on Kinnate Biopharma Inc.
2023-11-09 16:05 | Q3 2023 Earnings Release |
2023-08-08 16:05 | Q2 2023 Earnings Release |
2023-06-15 12:20 | Goldman Sachs Global Healthcare Conference |
2023-06-09 12:00 | Annual General Meeting |
2023-06-07 14:30 | Jefferies Global Healthcare Conference |
2023-05-11 16:06 | Q1 2023 Earnings Release |
2023-04-18 13:30 | American Association for Cancer Research Meeting - Abstract No: 4927 |
2023-04-17 17:30 | American Association for Cancer Research Meeting |
2023-04-17 15:35 | American Association for Cancer Research Meeting - Abstract No: 9851 |
2023-04-13 | American Association for Cancer Research Meeting - Booth #1725 |
2023-03-15 16:05 | Q4 2022 Earnings Release |
2023-02-17 15:30 | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No:TPS593 |
2023-02-14 13:40 | SVB Securities Global Biopharma Conference |
2023-01-20 15:00 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: TPS637 |
2022-11-10 16:05 | Q3 2022 Earnings Release |
2022-09-22 12:30 | Piper Sandler Heartland Summit |
2022-09-09 09:10 | Wells Fargo Healthcare Conference |
2022-08-11 16:05 | Interim 2022 Earnings Release |
2022-08-10 10:20 | Wedbush PacGrow Healthcare Conference |
2022-06-15 13:00 | Goldman Sachs Global Healthcare Conference - Fireside Chat |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | 0,00 | -35,9 -36,0 0.23% | -90,0 -88,1 -2.17% | -118 -117 -0.5% | -120 -118 -1.96% |
EBIT Million USD | Released Forecast Spread | 0,00 | -36,0 -37,2 3.34% | -90,1 -89,6 -0.6% | -119 -117 -1.26% | -121 -121 0.16% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -35,8 -37,4 4.33% | -89,8 -89,3 -0.48% | -116 -116 -0.34% | -113 -115 2.25% |
Net income Million USD | Released Forecast Spread | -9,94 | -35,8 -37,4 4.33% | -89,8 -89,3 -0.47% | -116 -116 0.17% | -113 -115 2.25% |
EPS USD | Released Forecast Spread | -2,72 | -5,28 -1,48 -257.97% | -2,06 -2,05 -0.39% | -2,64 -2,64 0.13% | -2,42 -2,47 1.83% |
Announcement Date | 04/09/20 | 29/03/21 | 28/03/22 | 15/03/23 | 28/03/24 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -26,3 -25,7 -2.16% | -27,1 -27,0 -0.37% | -27,4 -28,1 2.64% | -31,4 -28,8 -8.98% | -32,7 -31,0 -5.47% | -34,7 -33,1 -4.73% | -34,1 -34,7 1.74% | -31,1 -32,5 4.28% | -19,3 -21,3 9.22% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,2 -25,7 -1.66% | -26,9 -27,1 0.55% | -27,1 -28,3 4.27% | -30,7 -28,5 -7.78% | -31,6 -30,7 -2.88% | -32,9 -33,1 0.4% | -31,9 -35,0 8.87% | -30,7 -32,7 5.96% | -10,8 -20,9 48.45% |
Net income Million USD | Released Forecast Spread | -26,2 -25,7 -1.66% | -26,9 -27,3 1.43% | -27,1 -28,4 4.81% | -30,7 -28,7 -7.09% | -31,6 -31,2 -1% | -32,9 -33,5 1.65% | -31,9 -35,2 9.3% | -30,7 -32,6 5.76% | -10,8 -20,9 48.45% |
EPS USD | Released Forecast Spread | -0,60 -0,59 -1.69% | -0,61 -0,62 1.35% | -0,62 -0,65 4.41% | -0,70 -0,60 -16.11% | -0,72 -0,71 -1.41% | -0,73 -0,74 1.35% | -0,68 -0,76 10.86% | -0,65 -0,69 6.19% | -0,36 -0,44 17.87% |
Announcement Date | 28/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 15/03/23 | 11/05/23 | 08/08/23 | 09/11/23 | 28/03/24 |
Past sector events for Kinnate Biopharma Inc.
2024-05-02 16:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 16:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 16:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 16:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
2024-05-02 08:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-02 06:30 | MODERNA, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- KNTE Stock
- Calendar Kinnate Biopharma Inc.